Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's disease
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement activation is elevated in human AD brain, especially in the presence of fibrillar amyloid plaques containing clusters of reactive microglia (8, 9, 11, 12)”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [9]
In the citing paper
“Complement cascade components, including C3 are significantly upregulated and associated with amyloid plaques, typically containing dystrophic neurites, in human AD (8, 9)”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [9]
In the citing paper
“Indeed, at later stages of AD pathogenesis in humans, various complement proteins and clusters of activated microglia have been found to colocalize with fibrillar amyloid plaques, often containing dystrophic neurites (8, 9).”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [9]
In the citing paper
“In humans, early, non-fibrillar diffuse plaques are associated with little or no microglial clustering (53) and accumulate little or no complement proteins (8, 9).”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [9]
Citations
Cites
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Abraham, C. R., Selkoe, D. J., & Potter, H. (1988) · Cell · doi:10.1016/0092-8674(88)90462-x · Cited by 900
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Snow, A. D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., & Wight, T. N. (1988) · PubMed Central · Cited by 456
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Self-citationComplement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
Self-citationCoria, F., Castaño, E., Prelli, F. C., Larrondo-Lillo, M., van Duinen, S. G., Shelanski, M. L., & Frangione, B. (1988) · PubMed · Cited by 245
Ogomori, K., Kitamoto, T., Tateishi, J., Sato, Y., Suetsugu, M., & Abe, M. (1989) · Europe PMC (PubMed Central) · Cited by 245
Rozemuller, J. M., Eikelenboom, P., Stam, F. C., Beyreuther, K., & Masters, C. L. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198911000-00009 · Cited by 243
Self-citationLévi-Strauss, M., & Mallat, M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2361 · Cited by 188
Research works printed but not linked: 1
- Haan, 1991, Hereditary cerebral hemorrhage with amyloidosis — Dutch type: its importance for Alzheimer's disease, TINS, 14, 231
Cited by
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
Complement in neurological disorders and emerging complement-targeted therapeutics
Dalakas, M. C., Alexopoulos, H., & Spaeth, P. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0400-0 · Cited by 363
Serum inflammatory proteins and cognitive decline in older persons
Dik, M. G., Jonker, C., Hack, C. E., Smit, J. H., Comijs, H. C., & Eikelenboom, P. (2005) · Neurology · doi:10.1212/01.wnl.0000158281.08946.68 · Cited by 339
Self-citationInflammatory mechanisms in Alzheimer's disease: implications for therapy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1105 · Cited by 326
Metadata
- Authors
- Eikelenboom, P., Hack, C. E., Kamphorst, W., & Rozemuller, J. M.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
- Venue
- Research in Immunology
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 143
- Issue
- 6
- Pages
- 617-620
- ISSN
- 0923-2494 (ISSN-L)
- OpenAlex
- W1998922446
- Cited by
- 40
- References
- 25
- Citations by year
- 2025: 2 · 2024: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Research in Immunology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, heparan sulfate proteoglycans, agrin, glypican-1, vascular amyloid, amyloid plaques, glycosaminoglycan synthesis, amyloid fibrils, complement proteins
- MeSH terms
- alpha 1-Antichymotrypsin, Alzheimer Disease, Brain, Complement System Proteins, Humans, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/0923-2494(92)80044-l
- The paper
- Eikelenboom, P., Hack, C. E., Kamphorst, W., & Rozemuller, J. M. (1992). Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's disease. Research in Immunology. https://doi.org/10.1016/0923-2494(92)80044-l
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.